Skip to content
Search

Latest Stories

Trump takes daily dose of hydroxychloroquine because he hears 'very good things' about it

DONALD TRUMP has disclosed that he is taking daily doses of antimalarial drug hydroxychloroquine to ward off the coronavirus, though health officials have warned it may be unsafe.

Speaking at a meeting of restaurant executives on Monday (18), the US president said he began taking the drug after consulting the White House doctor.


"A couple of weeks ago, I started taking it," he told reporters, asserting that he has zero symptoms of the deadly Covid-19, which has killed over 90,000 Americans in the past three months.

"I have been taking it (hydroxychloroquine) for about a week and a half.”

There is no evidence hydroxychloroquine can fight off coronavirus, though clinical trials are under way. Medical experts and the US Food and Drug Administration have questioned the efficacy of the antimalarial drug and  warned of the potentially harmful side effects.

“The White House doctor didn't recommend. I asked him, what do you think? He said well, if you'd like it. I said yeah, I'd like it. I'd like to take it,” he said.

“I take a pill every day. At some point, I'll stop. What I'd like to do is I'd like to have the cure and/or the vaccine, and that will happen, I think, very soon.”

Soon after Trump revealed to the world that he has been taking the medicine, the White House doctor said the president is in good health.

“The president is in very good health and remains symptom-free. He receives regular Covid-19 testing, all negative to date,” said White House physician, Dr Sean P Conley.

“After numerous discussions, he and I had regarding the evidence for and against the use of hydroxychloroquine, we concluded the potential benefit from treatment outweighed the relative risk.”

Trump rubbished claims that he was promoting hydroxychloroquine due to business interests.

“I don't take it because... hey, people said oh maybe he owns the company. No, I don't own the company You know what, I want the people of this nation to feel good. I don't want them being sick. And there's a very good chance that this has an impact, especially early on,” he said.

“I take it (hydroxychloroquine) because I think I hear very good things. Again, you have to go to frontline workers. Many frontline workers take it, and they seem to be doing very well.”

The president said he has zero symptoms of coronavirus.

“No, I haven't had any symptoms. I test every couple of days they want to test me, you know, for obvious reasons. So every couple of days I get tested, and I've shown always negative, right, negative. …. Totally negative, no symptoms, no nothing,” he said.

Hydroxychloroquine sulfate was first synthesised in 1946 and is in a class of medications historically used to treat and prevent malaria.

It is approved by the US Food and Drug Administration to treat malaria, rheumatoid arthritis, lupus, childhood arthritis, and other autoimmune diseases.

The drug is not FDA-approved for the treatment of Covid-19 but it has been identified as a possible treatment for the infection and the US government has requested its immediate availability.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less